Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

Lupin's shares recovered after strong Q3 FY25 results, with a net profit of ₹858.9 crore, up 38.8%. North America sales grew ...

Lupin shares saw a strong recovery on February 12 after the company reported solid Q3 FY25 earnings. The stock, which ...

In a choppy trade, led by gains in financial and metal stocks, indices ended off day's low with Nifty holding on to 23,000 ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

The company reported a profit after tax of ₹8,589 crore, a 38.8% increase from the previous year's ₹6,187 crore. Its total ...

Lupin Limited reports 39.5% profit increase, strong performance in North America and Europe, maintaining market leadership in ...

The share price of Lupin Ltd. fell over 3% on Wednesday despite a 39.5% jump in its net profit for the quarter ended December. The decline comes as Nifty fell below 23,000 support level. In addition, ...

The Board also approved the incorporation of a wholly owned subsidiary in the name and style LUPINLIFE Consumer Healthcare or any other appropriate name, as may be approved by the Ministry of ...

Steel Authority of India, Ircon International Ltd., Hindustan Aeronautics Ltd., Vodafone Idea Ltd., Lupin Ltd., and Bayer ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...